Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non–COVID-19 Indications, 2020-2021

IMPORTANCE: Effective COVID-19 vaccines and therapeutics reached the market within the first year of the pandemic. This rate of development and availability was an unprecedented achievement that required attention to numerous research and development, regulatory, and policy challenges. However, only...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelis, Aris, Suarez Alonso, Carlos, Kyriopoulos, Ilias, Mossialos, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382437/
https://www.ncbi.nlm.nih.gov/pubmed/35972740
http://dx.doi.org/10.1001/jamanetworkopen.2022.26892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382437/
https://www.ncbi.nlm.nih.gov/pubmed/35972740
http://dx.doi.org/10.1001/jamanetworkopen.2022.26892

Ejemplares similares